BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8002646)

  • 21. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
    Zimmermann R; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An association of idiopathic chronic eosinophilic pneumonia with pemphigoid nodularis: a rare variant of bullous pemphigoid.
    Koga H; Hamada T; Ohyama B; Nakama T; Yasumoto S; Hashimoto T
    Arch Dermatol; 2009 Nov; 145(11):1339-40. PubMed ID: 19917977
    [No Abstract]   [Full Text] [Related]  

  • 23. Lichen planus pemphigoides: combination therapy with tetracycline and nicotinamide.
    Fivenson DP; Kimbrough TL
    J Am Acad Dermatol; 1997 Apr; 36(4):638-40. PubMed ID: 9092758
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.
    Tirado-Sánchez A; Díaz-Molina V; Ponce-Olivera RM
    Allergol Immunopathol (Madr); 2012; 40(3):152-5. PubMed ID: 21497011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study].
    Morel P; Guillaume JC
    Ann Dermatol Venereol; 1984; 111(10):925-8. PubMed ID: 6395773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bullous pemphigoid: course of the disease. A study of 25 patients.
    Carro-Jiménez EJ; Sánchez JL
    Bol Asoc Med P R; 2003; 95(4):27-8, 33-5. PubMed ID: 15032026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents.
    McCarty M; Fivenson D
    J Am Acad Dermatol; 2014 Sep; 71(3):475-9. PubMed ID: 24906610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
    Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Juvenile bullous pemphigoid: the presentation and follow-up of six cases.
    Gajic-Veljic M; Nikolic M; Medenica L
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):69-72. PubMed ID: 19453790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
    Honl BA; Elston DM
    Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of generalized bullous pemphigoid with oral tetracycline.
    Thomas I; Khorenian S; Arbesfeld DM
    J Am Acad Dermatol; 1993 Jan; 28(1):74-7. PubMed ID: 8425974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.
    Borden LS; Clark PE; Lovato J; Hall MC; Stindt D; Harmon M; M Mohler R; Torti FM
    Cancer; 2006 Sep; 107(5):1093-100. PubMed ID: 16888761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bullous pemphigoid treated by topical corticosteroids.
    Paquet P; Richelle M; Lapiere CM
    Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of ocular cicatricial pemphigoid with sulfasalazine].
    Le Rouic JF; Robin H; Doan S; Prisant O; Belayachi N; Hoang-Xuan T
    J Fr Ophtalmol; 1999 May; 22(4):423-5. PubMed ID: 10365328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bullous pemphigoid--a report of 86 cases from Taiwan.
    Chang YT; Liu HN; Wong CK
    Clin Exp Dermatol; 1996 Jan; 21(1):20-2. PubMed ID: 8689763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bullous pemphigoid and multiple sclerosis].
    Tohme A; Mattar L; Zebouni A; Koussa S
    Ann Dermatol Venereol; 1994; 121(2):139-42. PubMed ID: 7979024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.